Burt Feuerstein, MD, PhD
Professor Emeritus
Laboratory Medicine
School of Medicine

Pediatrics and fellowship in Pediatric Hematology/Oncology at the University of California San Francisco, was professor of Lab Medicine and Neurological Surgery at UCSF, and is emeritus since 2006. Burt moved to Barrow Neurological Institute in 2006, and joined the University of Arizona College of Medicine – Phoenix in 2010. He is Professor of Child Health and Neurology, and retired in 2018. His present academic interests include drug development, brain tumor diagnosis and therapy, medical ethics in human research, and mentoring.

PATENT INFORMATION for Dr. Burt Feuerstein:

Therapeutic polyamines Inventors: Basu; Hirak S. (Pacifica, CA), Feuerstein; Burt (San Francisco, CA), Marton; Laurence (Fitchburg, WI), Samejima; Keijiro (Kokubunji, Tokyo 185, JP) Family ID: 22521929 Appl. No.: 08/147,527 Filed: November 5, 1993

Therapeutic polyamines Inventors: Feuerstein; Burt G. (San Francisco, CA), Mohapatra; Gayatry (San Francisco, CA), Kim; Dong H. (San Francisco, CA) Assignee: The Regents of the University of California (Oakland, CA) Family ID: 23595852 Appl. No.: 08/403,457 Filed: March 14, 1995

Genetic gain and loss in gliomas Inventors: Feuerstein; Burt G. (San Francisco, CA), Mohapatra; Gayatry (San Francisco, CA), Kim; Dong H. (San Francisco, CA) Assignee: The Regents of the University of California (Oakland, CA) Family ID: 23595852 Appl. No.: 08/403,457 Filed: March 14, 1995

Glioma-associated nucleic acid probes Inventors: Feuerstein; Burt G. (San Francisco, CA), Mohapatra; Gayatry (San Francisco, CA), Kim; Dong Hyung (San Francisco, CA) Assignee: The Regents of the University of California (Oakland, CA) Family ID: 23595852 Appl. No.: 08/812,609 Filed: March 6, 1997

• Clinicopathologic features of pediatric oligodendrogliomas: a series of 50 patients.
  The American journal of surgical pathology 2014 Rodriguez FJ, Tihan T, Lin D, McDonald W, Nigro J, Feuerstein B, Jackson S, Cohen K, Burger PC
• AKT pathway genes define 5 prognostic subgroups in glioblastoma.
  PloS one 2014 Joy A, Ramesh A, Smirnov I, Reiser M, Misra A, Shapiro WR, Mills GB, Kim S, Feuerstein BG
• Sulforhodamine 101 selectively labels human astrocytoma cells in an animal model of glioblastoma.
  Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2014 Georges JF, Martirosyan NL, Eschbacher J, Nichols J, Tissot M, Preul MC, Feuerstein B, Anderson T, Spetzler RF, Nakaji P
• Label-free microscopic assessment of glioblastoma biopsy specimens prior to biobanking [corrected].
  Neurosurgical focus 2014 Georges J, Zehri A, Carlson E, Nichols J, Mooney MA, Martirosyan NL, Ghaffari L, Kalani MY, Eschbacher J, Feuerstein B, Anderson T, Preul MC, Van Keuren-Jensen K, Nakaji P
• Molecular interactions of ErbB1 (EGFR) and integrin-β1 in astrocytoma frozen sections predict clinical outcome and correlate with Akt-mediated in vitro radioresistance.
  Neuro-oncology 2013 Petrás M, Lajtos T, Friedländer E, Klekner A, Pintye E, Feuerstein BG, Szöllosi J, Vereb G
• Intraoperative fluorescent imaging of intracranial tumors: a review.
  Clinical neurology and neurosurgery 2013 Behbahaninia M, Martirosyan NL, Georges J, Udovich JA, Kalani MY, Feuerstein BG, Nakaji P, Spetzler RF, Preul MC
• DNA copy number alterations in central primitive neuroectodermal tumors and tumors of the pineal region: an international individual patient data meta-analysis.
  Journal of neuro-oncology 2012 von Bueren AO, Gerss J, Hagel C, Cai H, Remke M, Hasselblatt M, Feuerstein BG, Pernet S, Delattre O, Korshunov A, Rutkowski S, Pfister SM, Baudis M
• Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival.
  Neuro-oncology 2012 Hu LS, Eschbacher JM, Heiserman JE, Dueck AC, Shapiro WR, Liu S, Karis JP, Smith KA, Coons SW, Nakaji P, Spetzler RF, Feuerstein BG, Debbins J, Baxter LC
• Correlations between perfusion MR imaging cerebral blood volume, microvessel quantification, and clinical outcome using stereotactic analysis in recurrent high-grade glioma.
  AJNR. American journal of neuroradiology 2011 Hu LS, Eschbacher JM, Dueck AC, Heiserman JE, Liu S, Karis JP, Smith KA, Shapiro WR, Pinnaduwage DS, Coons SW, Nakaji P, Debbins J, Feuerstein BG, Baxter LC
• The Wnt inhibitory factor 1 (WIF1) is targeted in glioblastoma and has a tumor suppressing function potentially by induction of senescence.
  Neuro-oncology 2011 Lambiv WL, Vassallo I, Delorenzi M, Shay T, Diserens AC, Misra A, Feuerstein B, Murat A, Migliavacca E, Hamou MF, Sciuscio D, Burger R, Domany E, Stupp R, Hegi ME
• Pituicytoma: characterization of a unique neoplasm by histology, immunohistochemistry, ultrastructure, and array-based comparative genomic hybridization.
  Archives of pathology & laboratory medicine 2010 Phillips JJ, Misra A, Feuerstein BG, Kunwar S, Tihan T
• A multigene predictor of outcome in glioblastoma.
  Neuro-oncology 2009 Colman H, Zhang L, Sulman EP, McDonald JM, Shooshtari NL, Rivera A, Popoff S, Nutt CL, Louis DN, Cairncross JG, Gilbert MR, Phillips HS, Mehta MP, Chakravarti A, Pelloski CE, Bhat K, Feuerstein BG, …
• Optimized preload leakage-correction methods to improve the diagnostic accuracy of dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in posttreatment gliomas.
  AJNR. American journal of neuroradiology 2009 Hu LS, Baxter LC, Pinnaduwage DS, Paine TL, Karis JP, Feuerstein BG, Schmainda KM, Dueck AC, Debbins J, Smith KA, Nakaji P, Eschbacher JM, Coons SW, Heiserman JE
• Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements.
  AJNR. American journal of neuroradiology 2008 Hu LS, Baxter LC, Smith KA, Feuerstein BG, Karis JP, Eschbacher JM, Coons SW, Nakaji P, Yeh RF, Debbins J, Heiserman JE
• Amplifying small amounts of tumor DNA allows detection of DNA copy number abberations with array-CGH.
  BioTechniques 2008 Prestegarden L, Misra A, Ware ML, Yeh RF, Bjerkvig R, Feuerstein BG
• Functional inactivation of the KLF6 tumor suppressor gene by loss of heterozygosity and increased alternative splicing in glioblastoma.
  International journal of cancer 2007 Camacho-Vanegas O, Narla G, Teixeira MS, DiFeo A, Misra A, Singh G, Chan AM, Friedman SL, Feuerstein BG, Martignetti JA
• Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature.
  Oncogene 2007 Tomioka N, Oba S, Ohira M, Misra A, Fridlyand J, Ishii S, Nakamura Y, Isogai E, Hirata T, Yoshida Y, Todo S, Kaneko Y, Albertson DG, Pinkel D, Feuerstein BG, Nakagawara A
• Contribution of Notch signaling activation to human glioblastoma multiforme.
  Journal of neurosurgery 2007 Kanamori M, Kawaguchi T, Nigro JM, Feuerstein BG, Berger MS, Miele L, Pieper RO
• Identification of IGF2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastoma.
  Proceedings of the National Academy of Sciences of the United States of America 2007 Soroceanu L, Kharbanda S, Chen R, Soriano RH, Aldape K, Misra A, Zha J, Forrest WF, Nigro JM, Modrusan Z, Feuerstein BG, Phillips HS
• Genetic aberrations in gliomatosis cerebri.
  Neurosurgery 2007 Ware ML, Hirose Y, Scheithauer BW, Yeh RF, Mayo MC, Smith JS, Chang S, Cha S, Tihan T, Feuerstein BG
• Angiogenesis-independent tumor growth mediated by stem-like cancer cells.
  Proceedings of the National Academy of Sciences of the United States of America 2006 Sakariassen PØ, Prestegarden L, Wang J, Skaftnesmo KO, Mahesparan R, Molthoff C, Sminia P, Sundlisaeter E, Misra A, Tysnes BB, Chekenya M, Peters H, Lende G, Kalland KH, Øyan AM, Petersen K, Jonassen …
• A genetic strategy to overcome the senescence of primary meningioma cell cultures.
  Journal of neuro-oncology 2006 Baia GS, Slocum AL, Hyer JD, Misra A, Sehati N, VandenBerg SR, Feuerstein BG, Deen DF, McDermott MW, Lal A
• Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.
  Cancer cell 2006 Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L, Williams PM, Modrusan Z, Feuerstein BG, Aldape K
• Chromosome transfer experiments link regions on chromosome 7 to radiation resistance in human glioblastoma multiforme.
  Genes, chromosomes & cancer 2006 Misra A, Pellarin M, Hu L, Kunwar S, Perhouse M, Lamborn KR, Deen DF, Feuerstein BG
• ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunction.
  Human molecular genetics 2005 Huang G, Krig S, Kowbel D, Xu H, Hyun B, Volik S, Feuerstein B, Mills GB, Stokoe D, Yaswen P, Collins C
• Biphasic calcium response of platelet-derived growth factor stimulated glioblastoma cells is a function of cell confluence.
  Cytometry. Part A : the journal of the International Society for Analytical Cytology 2005 Vereb G, Feuerstein BG, Hyun WC, Fulwyler MJ, Balázs M, Szöllosi J
• Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patients.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2005 Pan E, Pellarin M, Holmes E, Smirnov I, Misra A, Eberhart CG, Burger PC, Biegel JA, Feuerstein BG
• Molecular cytogenetic analysis of chromosomes 1 and 19 in glioma cell lines.
  Cancer genetics and cytogenetics 2005 Law ME, Templeton KL, Kitange G, Smith J, Misra A, Feuerstein BG, Jenkins RB
• Array comparative genomic hybridization identifies genetic subgroups in grade 4 human astrocytoma.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2005 Misra A, Pellarin M, Nigro J, Smirnov I, Moore D, Lamborn KR, Pinkel D, Albertson DG, Feuerstein BG
• Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma.
  Cancer research 2005 Nigro JM, Misra A, Zhang L, Smirnov I, Colman H, Griffin C, Ozburn N, Chen M, Pan E, Koul D, Yung WK, Feuerstein BG, Aldape KD
• Expression of the aquaporin-1 water channel in human glial tumors.
  Neurosurgery 2005 Oshio K, Binder DK, Liang Y, Bollen A, Feuerstein B, Berger MS, Manley GT
• Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas.
  Genes, chromosomes & cancer 2005 Kitange G, Misra A, Law M, Passe S, Kollmeyer TM, Maurer M, Ballman K, Feuerstein BG, Jenkins RB
• A complex rearrangement of chromosome 7 in human astrocytoma.
  Cancer genetics and cytogenetics 2004 Misra A, Pellarin M, Shapiro JR, Feuerstein BG
• Grade II astrocytomas are subgrouped by chromosome aberrations.
  Cancer genetics and cytogenetics 2003 Hirose Y, Aldape KD, Chang S, Lamborn K, Berger MS, Feuerstein BG
• Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma.
  Cancer research 2002 Burton EC, Lamborn KR, Feuerstein BG, Prados M, Scott J, Forsyth P, Passe S, Jenkins RB, Aldape KD
• Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors.
  Nature genetics 2002 Zardo G, Tiirikainen MI, Hong C, Misra A, Feuerstein BG, Volik S, Collins CC, Lamborn KR, Bollen A, Pinkel D, Albertson DG, Costello JF
• Genetic subgroups of anaplastic astrocytomas correlate with patient age and survival.
  Cancer research 2001 Kunwar S, Mohapatra G, Bollen A, Lamborn KR, Prados M, Feuerstein BG
• Losses of chromosomal arms 1p and 19q in the diagnosis of oligodendroglioma. A study of paraffin-embedded sections.
  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2001 Burger PC, Minn AY, Smith JS, Borell TJ, Jedlicka AE, Huntley BK, Goldthwaite PT, Jenkins RB, Feuerstein BG
• Tissue microdissection and degenerate oligonucleotide primed-polymerase chain reaction (DOP-PCR) is an effective method to analyze genetic aberrations in invasive tumors.
  The Journal of molecular diagnostics : JMD 2001 Hirose Y, Aldape K, Takahashi M, Berger MS, Feuerstein BG
• Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups.
  The American journal of pathology 2001 Hirose Y, Aldape K, Bollen A, James CD, Brat D, Lamborn K, Berger M, Feuerstein BG
• Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification.
  International journal of cancer 2001 Plantaz D, Vandesompele J, Van Roy N, Lastowska M, Bown N, Combaret V, Favrot MC, Delattre O, Michon J, Bénard J, Hartmann O, Nicholson JC, Ross FM, Brinkschmidt C, Laureys G, Caron H, Matthay KK, …
• Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic subgroups are there?
  Medical and pediatric oncology 2001 Vandesompele J, Speleman F, Van Roy N, Laureys G, Brinskchmidt C, Christiansen H, Lampert F, Lastowska M, Bown N, Pearson A, Nicholson JC, Ross F, Combaret V, Delattre O, Feuerstein BG, Plantaz D
• Astroblastoma: clinicopathologic features and chromosomal abnormalities defined by comparative genomic hybridization.
  Brain pathology (Zurich, Switzerland) 2000 Brat DJ, Hirose Y, Cohen KJ, Feuerstein BG, Burger PC
• Detection of p16, RB, CDK4, and p53 gene deletion and amplification by fluorescence in situ hybridization in 96 gliomas.
  American journal of clinical pathology 1999 Perry A, Anderl K, Borell TJ, Kimmel DW, Wang CH, O'Fallon JR, Feuerstein BG, Scheithauer BW, Jenkins RB
• Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors.
  Cancer 1999 Russo C, Pellarin M, Tingby O, Bollen AW, Lamborn KR, Mohapatra G, Collins VP, Feuerstein BG
• Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype.
  Oncogene 1999 Smith JS, Alderete B, Minn Y, Borell TJ, Perry A, Mohapatra G, Hosek SM, Kimmel D, O'Fallon J, Yates A, Feuerstein BG, Burger PC, Scheithauer BW, Jenkins RB
• Chromosomal abnormalities in glioblastoma multiforme by comparative genomic hybridization: correlation with radiation treatment outcome.
  Clinical cancer research : an official journal of the American Association for Cancer Research 1999 Huhn SL, Mohapatra G, Bollen A, Lamborn K, Prados MD, Feuerstein BG
• Multiple genetic aberrations including evidence of chromosome 11q13 rearrangement detected in pituitary adenomas by comparative genomic hybridization.
  Journal of neurosurgery 1999 Metzger AK, Mohapatra G, Minn YA, Bollen AW, Lamborn K, Waldman FM, Wilson CB, Feuerstein BG
• CNS Resident Award. Malignant meningiomas frequently lose multiple chromosomal regions in addition to 22q: putative meningioma progression loci identified by comparative genomic hybridization.
  Clinical neurosurgery 1999 Metzger AK, Minn YA, Lieberman D, Bollen AW, Wilson CB, Feuerstein BG
• EGF-induced redistribution of erbB2 on breast tumor cells: flow and image cytometric energy transfer measurements.
  Cytometry 1998 Nagy P, Bene L, Balázs M, Hyun WC, Lockett SJ, Chiang NY, Waldman F, Feuerstein BG, Damjanovich S, Szöllosi J
• Genetic analysis of glioblastoma multiforme provides evidence for subgroups within the grade.
  Genes, chromosomes & cancer 1998 Mohapatra G, Bollen AW, Kim DH, Lamborn K, Moore DH, Prados MD, Feuerstein BG
• Effects of DFMO on glioma cell proliferation, migration and invasion in vitro.
  Journal of neuro-oncology 1998 Terzis AJ, Pedersen PH, Feuerstein BG, Arnold H, Bjerkvig R, Deen DF
• Gliomas in families: chromosomal analysis by comparative genomic hybridization.
  Cancer genetics and cytogenetics 1998 Patel A, van Meyel DJ, Mohapatra G, Bollen A, Wrensch M, Cairncross JG, Feuerstein BG
• Analyses of brain tumor cell lines confirm a simple model of relationships among fluorescence in situ hybridization, DNA index, and comparative genomic hybridization.
  Genes, chromosomes & cancer 1997 Mohapatra G, Moore DH, Kim DH, Grewal L, Hyun WC, Waldman FM, Pinkel D, Feuerstein BG
• Intraoperative discovery of neuroblastoma in an infant with pulmonary atresia.
  The Annals of thoracic surgery 1997 McElhinney DB, Reddy VM, Feuerstein BG, Marx GR, Hanley FL
• Detection of p16 gene deletions in gliomas: a comparison of fluorescence in situ hybridization (FISH) versus quantitative PCR.
  Journal of neuropathology and experimental neurology 1997 Perry A, Nobori T, Ru N, Anderl K, Borell TJ, Mohapatra G, Feuerstein BG, Jenkins RB, Carson DA
• Targeted expression of MYCN causes neuroblastoma in transgenic mice.
  The EMBO journal 1997 Weiss WA, Aldape K, Mohapatra G, Feuerstein BG, Bishop JM
• Cellular analysis of the mode of action of methyl-3,5-diiodo-4-(4'-methoxyphenoxy) benzoate (DIME) on tumor cells.
  International journal of oncology 1997 Zhen J, Feuerstein B, Vidair C, Hyun W, Young L, Kirsten E, Kun E
• The peripheral myelin protein 22 kDa (PMP22) gene is amplified in cell lines derived from glioma and osteogenic sarcoma.
  International journal of oncology 1997 Liehr T, Park O, Feuerstein B, Gebhart E, Rautenstrauss B
• Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization.
  The American journal of pathology 1997 Plantaz D, Mohapatra G, Matthay KK, Pellarin M, Seeger RC, Feuerstein BG
• Depletion of intracellular calcium stores facilitates the influx of extracellular calcium in platelet derived growth factor stimulated A172 glioblastoma cells.
  Cytometry 1996 Vereb G, Szöllösi J, Mátyus L, Balázs M, Hyun WC, Feuerstein BG
• Patterns of epidermal growth factor receptor amplification in malignant gliomas.
  The American journal of pathology 1996 Sauter G, Maeda T, Waldman FM, Davis RL, Feuerstein BG
• The ability of polyamine analogues to induce Z-DNA structure in synthetic polynucleotides in vitro inversely correlates with their effects on cytotoxicity of cis-diaminedichloroplatinum (II) (CDDP) in human brain tumor cell lines.
  Anticancer research 1996 Basu HS, Pellarin M, Feuerstein BG, Marton LJ
• Spermine uptake is necessary to induce haemoglobin synthesis in murine erythroleukaemia cells.
  The Biochemical journal 1995 Clément S, Delcros JG, Feuerstein BG
• A new model for disruption of the ornithine decarboxylase gene, SPE1, in Saccharomyces cerevisiae exhibits growth arrest and genetic instability at the MAT locus.
  The Biochemical journal 1995 Schwartz B, Hittelman A, Daneshvar L, Basu HS, Marton LJ, Feuerstein BG
• ERBB-2 (HER2/neu) gene copy number, p185HER-2 overexpression, and intratumor heterogeneity in human breast cancer.
  Cancer research 1995 Szöllösi J, Balázs M, Feuerstein BG, Benz CC, Waldman FM
• Heterogeneity, polyploidy, aneusomy, and 9p deletion in human glioblastoma multiforme.
  Cancer genetics and cytogenetics 1995 Park SH, Maeda T, Mohapatra G, Waldman FM, Davis RL, Feuerstein BG
• Spermine induces haemoglobin synthesis in murine erythroleukaemia cells.
  The Biochemical journal 1995 Delcros JG, Schwartz B, Clément S, Basu HS, Marton LJ, Feuerstein BG
• The structure of polyamine analogues determines haemoglobin production and cytotoxicity in murine erythroleukaemia cells.
  The Biochemical journal 1995 Clément S, Delcros JG, Basu HS, Quash G, Marton LJ, Feuerstein BG
• Detection of multiple gains and losses of genetic material in ten glioma cell lines by comparative genomic hybridization.
  Genes, chromosomes & cancer 1995 Mohapatra G, Kim DH, Feuerstein BG
• Chromosomal abnormalities in glioblastoma multiforme tumors and glioma cell lines detected by comparative genomic hybridization.
  International journal of cancer 1995 Kim DH, Mohapatra G, Bollen A, Waldman FM, Feuerstein BG
• Radiation-induced changes in nucleoid halo diameters of aerobic and hypoxic SF-126 human brain tumor cells.
  Cytometry 1995 Wang J, Basu HS, Hu L, Feuerstein BG, Nederlof PM, Deen DF
• Molecular cytogenetic quantitation of gains and losses of genetic material from human gliomas.
  Journal of neuro-oncology 1995 Feuerstein BG, Mohapatra G
• Two polyamine analogs (BE-4-4-4 and BE-4-4-4-4) directly affect growth, survival, and cell cycle progression in two human brain tumor cell lines.
  Cancer chemotherapy and pharmacology 1995 Bergeron CJ, Basu HS, Marton LJ, Deen DF, Pellarin M, Feuerstein BG
• Design and testing of novel cytotoxic polyamine analogues.
  Cancer research 1994 Basu HS, Marton LJ, Pellarin M, Deen DF, McManis JS, Liu CZ, Bergeron RJ, Feuerstein BG
• Pretreatment with the polyamine analog 1,19-bis-(ethylamino)-5,10,15-triazanonadecane (BE-4-4-4-4) inhibits etoposide cytotoxicity in U-251 MG (NCI) human brain tumor cells.
  Cellular and molecular biology (Noisy-le-Grand, France) 1994 Smirnov IV, Feuerstein BG, Pellarin M, Marton LJ, Deen DF, Basu HS
• Effect of 1,19-bis(ethylamino)-5,10,15-triazanonadecane on human tumor xenografts.
  Cancer research 1994 Dolan ME, Fleig MJ, Feuerstein BG, Basu HS, Luk GD, Casero RA, Marton LJ
• Scrapie prions alter receptor-mediated calcium responses in cultured cells.
  Neurology 1993 Kristensson K, Feuerstein B, Taraboulos A, Hyun WC, Prusiner SB, DeArmond SJ
• Effects of the polyamine analogs BE-3-7-3, 3-8-3, and BE-3-8-3 on human brain tumor cell growth and survival.
  Anticancer research 1993 Basu HS, Pellarin M, Feuerstein BG, Deen DF, Marton LJ
• Interaction of a polyamine analogue, 1,19-bis-(ethylamino)-5,10,15- triazanonadecane (BE-4-4-4-4), with DNA and effect on growth, survival, and polyamine levels in seven human brain tumor cell lines.
  Cancer research 1993 Basu HS, Pellarin M, Feuerstein BG, Shirahata A, Samejima K, Deen DF, Marton LJ
• Effects of ciglitazone on blood pressure and intracellular calcium metabolism.
  Hypertension (Dallas, Tex. : 1979) 1993 Pershadsingh HA, Szollosi J, Benson S, Hyun WC, Feuerstein BG, Kurtz TW
• Differential effects of spermine and its analogues on the structures of polynucleotides complexed with ethidium bromide.
  The Biochemical journal 1993 Delcros JG, Sturkenboom MC, Basu HS, Shafer RH, Szöllösi J, Feuerstein BG, Marton LJ
• alpha-Difluoromethylornithine alters calcium signaling in platelet-derived growth factor-stimulated A172 brain tumor cells in culture.
  Cancer research 1992 Feuerstein BG, Szöllösi J, Basu HS, Marton LJ
• Effect of polyamine depletion on chromatin structure in U-87 MG human brain tumour cells.
  The Biochemical journal 1992 Basu HS, Sturkenboom MC, Delcros JG, Csokan PP, Szollosi J, Feuerstein BG, Marton LJ
• Effect on N1,N14-bis-(ethyl)-homospermine (BE-4-4-4) on the growth of U-251 MG and SF-188 human brain tumor cells.
  International journal of cancer 1991 Basu HS, Pellarin M, Feuerstein BG, Deen DF, Marton LJ
• Calcium channels in PDGF-stimulated A172 cells open after intracellular calcium release and are not voltage-dependent.
  Cell calcium 1991 Szöllösi J, Feuerstein BG, Vereb G, Pershadsingh HA, Marton LJ
• Fluorescent tetradecanoylphorbol acetate: a novel probe of phorbol ester binding domains.
  Journal of cellular biochemistry 1991 Balázs M, Szöllösi J, Lee WC, Haugland RP, Guzikowski AP, Fulwyler MJ, Damjanovich S, Feuerstein BG, Pershadsingh HA
• 1H and 31P nuclear magnetic resonance studies of spermine binding to the Z-DNA form of d(m5CGm5CGm5CG)2. Evidence for decreased spermine mobility.
  Journal of molecular biology 1991 Banville DL, Feuerstein BG, Shafer RH
• Implications and concepts of polyamine-nucleic acid interactions.
  Journal of cellular biochemistry 1991 Feuerstein BG, Williams LD, Basu HS, Marton LJ
• Attachment of A172 human glioblastoma cells affects calcium signalling: a comparison of image cytometry, flow cytometry, and spectrofluorometry.
  Cytometry 1991 Szöllösi J, Feuerstein BG, Hyun WC, Das MK, Marton LJ
• Effects of variation in the structure of spermine on the association with DNA and the induction of DNA conformational changes.
  The Biochemical journal 1990 Basu HS, Schwietert HC, Feuerstein BG, Marton LJ